Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products
Sector:
Health Technology
Industry:
Biotechnology
Employees:
447
Frequently Asked Questions
What is Market Cap of Kite Pharma, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kite Pharma, Inc. market cap is $10.26B.
What is the 52-week high for Kite Pharma, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kite Pharma, Inc. 52 week high is $179.95 as of September 08, 2025.
What is the 52-week low for Kite Pharma, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kite Pharma, Inc. 52 week low is $39.82 as of September 08, 2025.
What is Kite Pharma, Inc. stock price today?
Kite Pharma, Inc. stock price today is $179.79.
What was Kite Pharma, Inc. stock price yesterday?
Kite Pharma, Inc. stock price yesterday was $179.81.
What is the PE ratio of Kite Pharma, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kite Pharma, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Kite Pharma, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kite Pharma, Inc. P/B ratio is 14.4689.
What is Kite Pharma, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Kite Pharma, Inc.'s EBITDA is N/A.
What is the 50-day moving average of Kite Pharma, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kite Pharma, Inc. 50-day moving average is $152.56.
